Nuno G. Graca
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 31, 2022
Improvement of recombinant ADAMTS13 production through a more optimal signal peptide or an N-terminal fusion protein.
Journal: Journal of thrombosis and haemostasis : JTH
Published: April 22, 2022
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases.
Journal: The Journal of allergy and clinical immunology
Published: March 10, 2022
TTP: From empiricism for an enigmatic disease to targeted molecular therapies.
Journal: British journal of haematology
Published: September 21, 2021
Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.
Journal: Frontiers in immunology
Published: August 11, 2021
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
Journal: Haematologica
Published: March 01, 2021
Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 16, 2020
Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura.
Journal: Haematologica
Published: November 21, 2019
PROFILE: Early-Stage Researchers Advancing Insights in TTP Through a Unique PhD Track.
Journal: HemaSphere
Published: February 14, 2018
Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
Journal: Haematologica
Published: January 11, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026